PDS Biotech raises $11M in registered direct offering; warrants could add $11M

PDS Biotechnology Corp

Gross proceeds of ~$11M upfront from sale of 7.33M shares and warrants; warrants exercisable at $1.50/share for 5 years.
Up to an additional $11M if all warrants are exercised for cash.
Directors participated at $1.66/unit; institutional investors at $1.50/unit.
Net proceeds ~$10.05M intended for R&D and general corporate purposes.
Closing expected Feb 28, 2025; insiders subject to 60-day lock-up.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.